Kronos Bio Q4 EPS $(1.13) Down From $(0.70) YoY

Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(1.13) per share. This is a 61.43 percent decrease over losses of $(0.70) per share from the same period last year.

Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(1.13) per share. This is a 61.43 percent decrease over losses of $(0.70) per share from the same period last year.

Total
0
Shares
Related Posts